Results 1 to 10 of about 138,235 (308)
Staging Non-Hodgkin Lymphoma [PDF]
Ca-A Cancer Journal for Clinicians, 2005 Non-Hodgkin Lymphomas are always treatable and frequently curable malignancies. However, choosing the most appropriate therapy requires accurate diagnosis and a careful staging evaluation. New patients with non-Hodgkin Lymphoma should have their tumors classified using the World Health Organization classification.
exaly +3 more sources
Composite follicular lymphoma and classic Hodgkin lymphoma [PDF]
Journal of Pathology and Translational Medicine, 2022 Composite lymphoma is very rare and a combination of Hodgkin lymphoma and non-Hodgkin lymphoma and even histiocytic tumors can occur. Because of the unfamiliarity, not only can this cause diagnostic problems, but can also affect treatment plan. We report
Han-Na Kim +5 more
doaj +1 more source
Head and Neck Lymphoma in an Iranian Population [PDF]
Iranian Journal of Otorhinolaryngology, 2017 Introduction: This study is aimed to assess the prevalence and characteristics of head and neck lymphoma in a defined group of an Iranian population. Materials and Methods: In this retrospective study, 126,450 biopsy reports from two referral Pathology
Nafiseh Shamloo +5 more
doaj +1 more source
The Egyptian Journal of Radiology and Nuclear Medicine, 2021 Background Malignant lymphoma accounts for nearly 20% of all mediastinal neoplasms in adults and 50% in children. Hodgkin’s disease is the most common primary mediastinal lymphoma.
Youssriah Yahia Sabri +3 more
doaj +1 more source
Journal of Contemporary Medicine, 2022 Aim: To evaluate the demographic and clinical characteristics, treatment approaches and outcomes of our pediatric patients with non-Hodgkin lymphoma diagnosed and treated in our center. Material and Methods: Between 2006 and 2002, the oncologic charts of
Kübra Ertan +3 more
doaj +1 more source
Maximum tumor diameter is associated with event-free survival in PET-negative patients with stage I/IIA Hodgkin lymphoma. [PDF]
, 2020 Introduction: the high cure rates achieved in early-stage (ES) Hodgkin lymphoma (HL) are one of the great successes of hemato-oncology, but late treatment-related toxicity undermines long-term survival.
Barrington, SF +11 more
core +3 more sources
Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma [PDF]
, 2012 Background: Hodkin s lymphoma is one of the most frequent lymphoma in western world. Despite an overall good prognosis some patients suffer relapsing tumors which are difficult to cure.
Benz, Alexander +2 more
core +2 more sources
Journal of the Royal College of Physicians of London, 1995 Significant advances in the understanding of non-Hodgkin's lymphoma (NHL) have occurred in the past two decades, resulting in changes in terminology and classification practices, which may affect the analysis of the Surveillance, Epidemiology, and End Results (SEER) data.The incidence rates for each subgroup of NHL in the Working Formulation were ...
T C, Greiner, L J, Medeiros, E S, Jaffe
openaire +4 more sources
Бюллетень сибирской медицины, 2011 126 patients with histological diagnosis of Hodgkin and non-Hodgkin lymphoma were examined using combined positronemission and computed tomography with radiotracer 18F-deoxyglucose. For staging Ann Arbor classification (1971) with Costwolds modification (
I. V. Boikov +2 more
doaj +1 more source
Primary extranodal non-Hodgkin lymphomas of the uterus and the breast: report of three cases [PDF]
, 1995 The authors describe one case of a rare primitive non-Hodgkin lymphoma of the uterus, and two cases of primary non-Hodgkin lymphoma of the breast. Histologically, the uterine lymphoma, although clinically confined to the uterus, was a diffuse large cell ...
Amato, C. +5 more
core +1 more source